These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 17261340)

  • 21. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies.
    Aksungur P; Sungur A; Unal S; Iskit AB; Squier CA; Senel S
    J Control Release; 2004 Aug; 98(2):269-79. PubMed ID: 15262418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chitosan in nasal delivery systems for therapeutic drugs.
    Casettari L; Illum L
    J Control Release; 2014 Sep; 190():189-200. PubMed ID: 24818769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery.
    Luppi B; Bigucci F; Mercolini L; Musenga A; Sorrenti M; Catenacci L; Zecchi V
    J Pharm Pharmacol; 2009 Feb; 61(2):151-7. PubMed ID: 19178761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
    GuhaSarkar S; Banerjee R
    J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation development of oral controlled release tablets of hydralazine: optimization of drug release and bioadhesive characteristics.
    Singh B; Pahuja S; Kapil R; Ahuja N
    Acta Pharm; 2009 Mar; 59(1):1-13. PubMed ID: 19304554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels.
    Perioli L; Ambrogi V; Venezia L; Pagano C; Ricci M; Rossi C
    Colloids Surf B Biointerfaces; 2008 Oct; 66(1):141-5. PubMed ID: 18621512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UEA I-bearing nanoparticles for brain delivery following intranasal administration.
    Gao X; Chen J; Tao W; Zhu J; Zhang Q; Chen H; Jiang X
    Int J Pharm; 2007 Aug; 340(1-2):207-15. PubMed ID: 17499948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.
    Siepmann J; Siepmann F; Florence AT
    Int J Pharm; 2006 May; 314(2):101-19. PubMed ID: 16647231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucoadhesion, hydration and rheological properties of non-aqueous delivery systems (NADS) for the oral cavity.
    Zaman MA; Martin GP; Rees GD
    J Dent; 2008 May; 36(5):351-9. PubMed ID: 18343013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low molecular weight quaternised chitosan (I): synthesis and characterisation.
    Snyman D; Govender T; Kotzé AF
    Pharmazie; 2003 Oct; 58(10):705-8. PubMed ID: 14609281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug release property of chitosan-pectinate beads and its changes under the influence of microwave.
    Wong TW; Nurjaya S
    Eur J Pharm Biopharm; 2008 May; 69(1):176-88. PubMed ID: 17980563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl.
    Diaz del Consuelo I; Falson F; Guy RH; Jacques Y
    J Control Release; 2007 Sep; 122(2):135-40. PubMed ID: 17688966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
    Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
    Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation and in vitro evaluation of bioadhesive liposome gels for local therapy of vaginitis.
    Pavelić Z; Skalko-Basnet N; Jalsenjak I
    Int J Pharm; 2005 Sep; 301(1-2):140-8. PubMed ID: 16024188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation.
    Sankar C; Rani M; Srivastava AK; Mishra B
    Pharmazie; 2001 Mar; 56(3):223-6. PubMed ID: 11265588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of thermosensitive chitosan-based hydrogels by rheology and electron paramagnetic resonance spectroscopy.
    Kempe S; Metz H; Bastrop M; Hvilsom A; Contri RV; Mäder K
    Eur J Pharm Biopharm; 2008 Jan; 68(1):26-33. PubMed ID: 17870449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system.
    Wu J; Wei W; Wang LY; Su ZG; Ma GH
    Biomaterials; 2007 Apr; 28(13):2220-32. PubMed ID: 17291582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Blatta orientalis (Q) nasal gel formulation in milk aspiration induced eosinophilia.
    Nimgulkar CC; Patil SD; Chauk DS
    Pharm Dev Technol; 2009; 14(4):435-41. PubMed ID: 19552565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
    Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
    Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.